QurieGen
PrivateLast Round
Pre Seed
Apr 8, 2025
Total Funding Raised
$2.63M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
QurieGen operates in Healthcare & Life Sciences and is based in Nijmegen. Its latest recorded funding round was a Pre Seed round in April 2025.
QurieGen is a biotechnology company that provides an AI-powered drug discovery platform integrating single-cell genomics and multi-omics to map cellular responses and accelerate therapeutic development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QurieGen Comparables
Compare QurieGen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellyrix Therapeutics | 85% | |
| Scailyte AG | 81% | |
| Cellarity | 78% |
For institutional investors. Book with your work email.
QurieGen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Apr 8, 2025 | ||||
| Grant | Apr 8, 2025 | ||||
| Grant | Dec 11, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
QurieGen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DIANA | Grant |
| Lighthouse Ventures | Pre Seed |
| Draper Associates | Pre Seed |
| Moondust Ventures | Pre Seed |
| Tensor Ventures | Pre Seed |
| BSV Ventures | Pre Seed |
| 22 Hor Invest | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 660% MoM, reaching 623.
- May 25, 2025
Added Cilag, S.A. from the Pharmaceuticals industry.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingNov 3, 2026
QurieGen and Rayca Precision are developing an iterative drug discovery workflow that connects novel target discovery, AI-driven molecular design, and experimental validation in a continuous learning process.
- attends_eventNov 3, 2026
QurieGen is attending BIO-Europe in Germany from Nov 9th '26 and is available for partnering meetings.
- partners_withNov 3, 2026
QurieGen and Rayca Precision Inc. announce a strategic partnership on Nov 3rd '26 in the Netherlands to connect target discovery, molecular design, and cellular validation for pharmaceutical R&D.
- recognized_asSep 9, 2026
Tech Funding News recognizes QurieGen as one of the 17 European deeptech startups to watch on Sep 9th '26.
For institutional investors. Book with your work email.
QurieGen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about QurieGen's valuation, stock price, and market status.
Is QurieGen a public or private company?
QurieGen is a private company.
What is the current stock price of QurieGen?
QurieGen is a private company, so its shares have no public market price. Caplight tracks QurieGen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is QurieGen worth (valuation)?
Valuation information for QurieGen is not publicly available.
Can I buy QurieGen stock?
QurieGen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was QurieGen's last funding round?
QurieGen's most recent funding round was Pre Seed on April 8, 2025.
Who are the main investors in QurieGen?
Key investors in QurieGen include Tensor Ventures.
Will QurieGen IPO soon?
No public IPO plans have been announced for QurieGen.
How can I track QurieGen secondary market activity?
Caplight tracks bids, offers, and trades in QurieGen's shares on secondary markets.